Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Integrated BioPharma Inc (INBP)
OTHER OTC:INBP
Holding INBP?
Track your performance easily
INBP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.16 - $0.35
Previous Close$0.34
Volume9.40K
Average Volume (3M)15.79K
Market Cap
$10.23M
Enterprise Value$9.52M
Total Cash (Recent Filing)$2.27M
Total Debt (Recent Filing)$1.56M
Price to Earnings (P/E)24.7
Beta0.34
Next Earnings
Feb 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding30,099,610
10 Day Avg. Volume7,318
30 Day Avg. Volume15,786
Standard Deviation0.16
R-Squared0.04
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)0.52
Price to Sales (P/S)0.20
Price to Cash Flow (P/CF)3.90
P/FCF Ratio4.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.19
Enterprise Value/Gross Profit2.45
Enterprise Value/Ebitda5.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
31.66%
Insiders
― Other Institutional Investors
68.34% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
INBP FAQ
What was Integrated BioPharma Inc’s price range in the past 12 months?
Integrated BioPharma Inc lowest stock price was $0.16 and its highest was $0.35 in the past 12 months.
What is Integrated BioPharma Inc’s market cap?
Currently, no data Available
When is Integrated BioPharma Inc’s upcoming earnings report date?
Integrated BioPharma Inc’s upcoming earnings report date is Feb 07, 2025 which is in 77 days.
How were Integrated BioPharma Inc’s earnings last quarter?
Integrated BioPharma Inc released its earnings results on Nov 13, 2024. The company reported $0.008 earnings per share for the quarter, beating the consensus estimate of N/A by $0.008.
Is Integrated BioPharma Inc overvalued?
According to Wall Street analysts Integrated BioPharma Inc’s price is currently Overvalued.
Does Integrated BioPharma Inc pay dividends?
Integrated BioPharma Inc does not currently pay dividends.
What is Integrated BioPharma Inc’s EPS estimate?
Integrated BioPharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Integrated BioPharma Inc have?
Integrated BioPharma Inc has 30,099,610 shares outstanding.
What happened to Integrated BioPharma Inc’s price movement after its last earnings report?
Integrated BioPharma Inc reported an EPS of $0.008 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 9.375%.
Which hedge fund is a major shareholder of Integrated BioPharma Inc?
Currently, no hedge funds are holding shares in INBP
---
Integrated BioPharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.82%
12-Months-Change
Fundamentals
Return on Equity
2.24%
Trailing 12-Months
Asset Growth
-1.72%
Trailing 12-Months
Company Description
Integrated BioPharma Inc
Integrated BioPharma, Inc. engages in the manufacture, distribution, marketing, and sale of vitamins, nutritional supplements and herbal products. It operates through the following segments: Contract Manufacturing, Branded Proprietary Products, and Other Nutraceutical Businesses. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers. The Branded Proprietary Products segment distributes nutritional products through mass market, grocery, drug and vitamin retailers. The Other Nutraceutical Businesses segment sells private label MDC products, as well as AgroLabs products. The company was founded by E. Gerald Kay in March 1980 and is headquartered in Hillside, NJ.
---
Technical Analysis
Ampio Pharmaceuticals
―
XTL Biopharmaceuticals Ltd. Sponsored ADR
―
Tonix Pharma
―
PTC Therapeutics
―
---